Bruker Corporation Appoints Dr. Gilles Martin to its Board of Directors
News Jan 20, 2014
Bruker Corporation has announced the election of Dr. Gilles Martin to its Board of Directors.
Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group, a Luxembourg-based international life-sciences company which provides a range of analytical testing services to clients across multiple industries.
Dr. Martin founded the original Eurofins Scientific Nantes food authenticity laboratory in 1988 and is a past President of the French Association of private analytical laboratories, and the North American Technical Committee for Juice and Juice Products. Dr. Martin holds a Ph.D. in Statistics and Applied Mathematics and a Master of Science from Syracuse University.
Frank Laukien, Bruker’s President and CEO, stated: “It is my great pleasure to welcome Gilles Martin to the Bruker Board of Directors as an independent director. I believe that Gilles will contribute strongly to the Bruker Board due to his tremendous entrepreneurial accomplishments at Eurofins, and with his in-depth knowledge of the environmental testing, food safety analysis and pharma CRO markets.”
Dr. Martin commented: “I am very excited to join the Board of Bruker, as the Company is expanding in the applied markets where I have extensive experience based upon my work at Eurofins. I hope that my general business and specific industry expertise, combined with the good work already being done by Bruker in the applied and CRO markets, can contribute to further profitable growth and the creation of shareholder value at Bruker.”
Academic Redesigns FDA-Approved MabThera to Treat ALSNews
Researchers have redesigned a portion of the FDA-apporved MabThera for better-targeted treatment of ALS.READ MORE
Biogen's MS Drug FAMPYRA Granted Standard Marketing Authorization in EUNews
Biogen's drug FAMPYRA improves walking for MS sufferers and has been granted standard marketing authorization.READ MORE
Cost-Efficient Chemical Reaction Could Yield New Fuels and MedicationsNews
UCLA scientists have developed a novel and inexpensive chemical reaction that can cut carbon-hydrogen bonds and incorporate methane into larger molecules.READ MORE
Comments | 0 ADD COMMENT
5th Annual Outscourcing in Clinical Trials Nordics 2017
Oct 10 - Oct 11, 2017